1. Di Giacomo, Danika, La Starza, Roberta, Gorello, Paolo, Piazza, Rocco, Mecucci, Cristina. . 14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia. In Blood, 138, 773-784. doi:10.1182/blood.2020010510. https://pubmed.ncbi.nlm.nih.gov/33876209/
2. Inoue, Jun, Ihara, Yusuke, Tsukamoto, Daisuke, Kominami, Ryo, Sato, Ryuichiro. 2017. BCL11B gene heterozygosity causes weight loss accompanied by increased energy consumption, but not defective adipogenesis, in mice. In Bioscience, biotechnology, and biochemistry, 81, 922-930. doi:10.1080/09168451.2016.1274642. https://pubmed.ncbi.nlm.nih.gov/28067590/
3. Daher, Marie-Thérèse, Bausero, Pedro, Agbulut, Onnik, Li, Zhenlin, Parlakian, Ara. 2020. Bcl11b/Ctip2 in Skin, Tooth, and Craniofacial System. In Frontiers in cell and developmental biology, 8, 581674. doi:10.3389/fcell.2020.581674. https://pubmed.ncbi.nlm.nih.gov/33363142/
4. Helm, Eric Y, Zelenka, Tomas, Cismasiu, Valeriu B, Bryceson, Yenan T, Avram, Dorina. 2023. Bcl11b sustains multipotency and restricts effector programs of intestinal-resident memory CD8+ T cells. In Science immunology, 8, eabn0484. doi:10.1126/sciimmunol.abn0484. https://pubmed.ncbi.nlm.nih.gov/37115913/
5. Przybylski, Grzegorz K, Przybylska, Julia, Li, Yangqiu. 2024. Dual role of BCL11B in T-cell malignancies. In Blood science (Baltimore, Md.), 6, e00204. doi:10.1097/BS9.0000000000000204. https://pubmed.ncbi.nlm.nih.gov/39295773/